Where Tech Meets Bio

Weekly Tech+Bio #87: TechBio 3.0 Is Closing the Loop. Is "Prompt to Drug" Next?

ALSO: ByteDance spins out Anew Labs on a $290M round; Lilly's TuneLab ships a nanobody developability model built on BigHat data; a partial…

Oct 13 • Andrii Buvailo, PhD and BiopharmaTrend

10

2

2

Weekly Tech+Bio #86: OpenAI Backs a Bet on “Rescuing“ Failed Drugs

ALSO: Enveda, Anew Labs and Varda raise over $850M between them; Genentech signs a $1.5B collaboration with Earendil; Neuralink pretrains on 50,000…

Oct 5 • Andrii Buvailo, PhD and BiopharmaTrend

13

7

1

September 2026

Weekly Tech+Bio #85: Big Pharma Is Betting On LLMs and Agents. What Would Count As Success?

ALSO: Iambic files for a Nasdaq IPO into a rebounding market; Up to $1.4B for desining oral macrocycles with AI; Stanford researchers turn manuscripts…

Sep 23 • Andrii Buvailo, PhD and BiopharmaTrend

12

2

Weekly Tech+Bio #84: A Chemist Designed a Drug Candidate with Help of ChatGPT and Gemini

ALSO: Scoring 9 billion DNA variants, agents in drug discovery stack, repurposing for cheap indications, whole-brain connectomics, brain-computer…

Sep 15 • Andrii Buvailo, PhD and BiopharmaTrend

17

1

3

August 2026

Weekly Tech+Bio #83: The FDA Might Test Clinical AI Like It Tests Doctors

ALSO: Can Claude design proteins? Ageing virtual cells, DNA as a programmable building material, and the tech+bio week in brief.

Aug 26 • Andrii Buvailo, PhD and BiopharmaTrend

10

4

3

Weekly Tech+Bio #82: Industry Vets Grade AI's Progress; Frontier AI Labs Enter CRO Industry; The Rise of In Vivo CAR-T, and More...

Also: IMPORTANT UPDATE ABOUT OUR NEWSLETTER

Aug 18 • Andrii Buvailo, PhD and BiopharmaTrend

6

6

2

July 2026

June 2026

My Seven Health Tech Observations From HLTH Europe 2026 Event

AI is moving from writing clinical notes to checking them. "Human-in-the-loop" is becoming a product, not a footnote. Nearly everyone is racing to own…

Jun 26 • Andrii Buvailo, PhD

16

1

Is the Future of AI Drug Discovery Hybrid?

Some field notes from the cutting edge of modern bioinformatics (CoFold Summit and Free Energy Workshop, both held recently in Barcelona, Spain). ALSO…

Jun 1 • Andrii Buvailo, PhD

29

2

May 2026

Is “Rescuing Failed Drugs with AI” a Category Now?

Inside the growing bet that AI can find the patients pharma's failed trials missed...

May 21 • Andrii Buvailo, PhD and Roman Kasianov

38

6

5

April 2026

From Biohacking to Healthcare: The Growing Pains of the Longevity Industry

Part I: A tour of the therapeutic strategies targeting the hallmarks of aging—from cellular reprogramming to senolytics, mTOR inhibitors, and immune…

Apr 16 • Louise von Stechow and BiopharmaTrend

33

2

7

Weekly Tech+Bio #81: AI Agents at the Cancer Conference

AI-pharma deals track toward a 12x increase in five years, Life Biosciences takes reprogramming to Phase 1, and Jeito closes Europe's largest…

Apr 14 • Roman Kasianov, Andrii Buvailo, PhD, and BiopharmaTrend

16

2